Article

Data reveals positive pre-clinical results for microplasmin

Researchers presented the pre-clinical results on Tuesday that evaluated the potential of microplasmin for the induction of posterior vitreous detachment (PVD).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
Related Content
New bill expands scope of practice for West Virginia optometrists
May 17th 2025

New bill expands scope of practice for West Virginia optometrists

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Q&A: Rishi Singh, MD, discusses real-world outcomes of patients with DME treated with faricimab
May 17th 2025

Q&A: Rishi Singh, MD, discusses real-world outcomes of patients with DME treated with faricimab

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Q&A: Anat Loewenstein, MD, and results of a consensus group on managing diabetic retinopathy
May 16th 2025

Q&A: Anat Loewenstein, MD, and results of a consensus group on managing diabetic retinopathy

LumiThera announces top-line results from LIGHTSITE IIIB extension trial assessing the Valeda Light Delivery System
May 15th 2025

LumiThera announces top-line results from LIGHTSITE IIIB extension trial assessing the Valeda Light Delivery System

© 2025 MJH Life Sciences

All rights reserved.